ArticleCellular & molecular immunology2021

Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors.

Zhenguang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.